A proposed rule (pdf) would focus on reducing costs through several regulations:
• Alignment of reimbursement rates that reflect the actual price the pharmacy pays for the prescription drug.
• An increase in rebates paid by drug manufacturers that participate in Medicaid.
• Drug rebates for Medicaid beneficiaries who are in a Medicaid managed care organization.
The proposed rule will be published in the Federal Register on Feb. 2, and comments can be submitted through April 2.
Related Articles on Prescription Drugs:
National Council for Prescription Drug Programs Announces 2011 Accomplishments
CVS Agrees to $5M Settlement with FTC
OIG: CMS Accepted $15.1M in Prescriptions Written by Excluded Providers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
